Pasar al contenido principal

HIDROGELES VISCOELASTICOS COMO PLATAFORMAS DE CULTIVO 3D DE CELULAS HEPATICAS PARA EL MODELADO DE LA ENFERMEDAD DEL HIGADO GRASO NO ALCOHOLICO

PID2022-136433OB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT POLITÈCNICA DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Injectable cell-laden gelatin-chondroitin sulphate hydrogels for liver in vitro models

  • Sanchez-Gonzalez, Estela
  • Tort-Ausina, Isabel|||0000-0002-1900-914X
  • Gallego-Ferrer, Gloria|||0000-0002-2428-0903
  • Naranjo-Alcazar, R.
  • Donato, M.T.
  • Salmerón Sánchez, Manuel
  • Tolosa-Pardo, Laia
[EN] Liver extracellular matrix-based models that precisely reproduce liver physiology and functions are required as 3D culture microenvironments for multiple applications in toxicology and metabolism, or for understanding the mechanisms implicated in liver disease. We introduced injectable gelatin-chondroitin sulphate (Gel/CS) hydrogels for culturing HepG2 cells, and evaluated the mechanical properties and functionality of cells in different Gel/CS compositions. The Gel/CS hydrogels exhibited soft mechanical properties and allowed the HepG2 culture. The characterisation and comparison of 3D cultures to standard monolayer systems revealed the regulation of key hepatic markers (i.e. CYP3A4, GSTA1) when cells were cultured in the Gel/CS hydrogels compared to 2D cultures, and also enhanced urea and albumin production, which would indicate increased cells functionality. This study underpins 3D in vitro models based on the Gel/CS hydrogels that can be used for different hepatology applications by offering increased predictivity and physiological relevance compared to current in vitro models., This study has been supported by the Institute of Health Carlos III and co-financed by the European Union through Grant PI21/00223, and by the Spanish Ministry of Science and Innovation MCIN/AEI/10.130 39/501100011033 by PID2022-136433OB-C21, PID2022-136433OB-C22 and CNS2022-135425 grants. This study has also been supported by the Generalitat Valenciana through Grant No. ACIF/2021/378 awarded to E.S.G., and by the Spanish Ministry of Science and Innovation through Grant PRE2020-094368 awarded to R.N.A.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Chitosan-copper microparticles as doxorubicin microcarriers for bone tumor therapy

  • Loncarevic, Andrea
  • Blanco-Gómez, Mireia
  • Rogina, Anamarija
  • Clara-Trujillo, Sandra|||0000-0002-6455-2993
  • Martínez-Férriz, Arantxa|||0000-0001-7193-2575
  • Gallego-Ferrer, Gloria|||0000-0002-2428-0903
[EN] Doxorubicin (DOX) is a chemotherapeutic drug used in osteosarcoma treatments, usually administrated in very high dosages. This study proposes novel DOX microcarriers based on chitosan (CHT) physically crosslinked with copper(II) ions that will act synergically to inhibit tumor growth at lower drug dosage without affecting the healthy cells. Spherical CHT-Cu microparticles with a smooth surface and an average size of 30.1 +/- 9.1 mu m were obtained by emulsion. The release of Cu 2 + ions from the CHT-Cu microparticles showed that 99.4 % of added cupric ions were released in 72 h of incubation in a complete cell culture medium (CCM). DOX entrapment in microparticles was conducted in a phosphate buffer solution (pH 6), utilizing the pH sensitivity of the polymer. The successful drug -loading process was confirmed by DOX emitting red fluorescence from drug -loaded microcarriers (DOX@CHT-Cu). The drug release in CCM showed an initial burst release, followed by sustained release. Biological assays indicated mild toxicity of CHT-Cu microparticles on the MG -63 osteosarcoma cell line, without affecting the viability of human mesenchymal stem cells (hMSCs). The DOX@CHT-Cu microparticles at concentration of 0.5 mg mL -1 showed selective toxicity toward MG -63 cells., This work was supported by the Croatian Science Foundation [grant number UIP-2020-02-6201] . G.G.F. acknowledges the support of the MCIN/AEI/10.13039/501100011033 grant PID2022-136433OB-C21 and Generalitat Valenciana CIPROM/2022/43 PROMETEO grant. A.M. F. acknowledges Programa Investigo 2022 (grant INVEST/2022/181) , Plan de Recuperacion, Transformacion y Resiliencia, by the European Union, Next Generation.